<p>HCT-116 CRC cells (A-D), the primary human colon cancer cells (two lines, “Colon can-1/2”, E) and the primary human colon epithelial cells (“Colon Epi1”, E) were either left untreated (“C”) or stimulated with TW-37 at applied concentrations (10–1000 nM), cells were further cultured in TW-37-containing-medium for designated time; Cell apoptosis was tested by the listed assays mentioned in the text. Cleaved-Caspase-9 and Cleaved-PARP were quantified and normalized to β-Tubulin (B). Data were presented as mean (n = 5) ± standard deviation (SD). *<i>p</i><0.05 vs. “C”. Experiments in this figure were repeated three times, and similar results were obtained.</p
<p>(A) Flow cytometric analysis of cell surface gp96 levels in breast cancer cells. (B) Cells were t...
Colorectal cancer (CRC) is one of the most common cancers in the Western world. 5-Fluorouracil (5FU)...
<p>(A) Apoptotic cells in IEC-18 cells pretreated with TLE (100 µg/ml; 45 min) and stimulated with T...
TW-37 is a novel, potent and non-peptide Bcl-2 small-molecule inhibitor. Its activity in colorectal ...
<p>A, HT-29 and T84 cells were treated for 24 h. Enzymatic activation of caspases 2, 3/7, 6, 8 and 9...
<p>Established CRC cell lines (HT-29, HCT116 and DLD-1), primary human CRC cells (two lines, “Pri1/2...
<p>a) Representative dot plot shows that, compared to vehicle-treated control cells, a significantly...
<p><b>A</b>. Caspase 3/7 activity of HT1080 and HCT116 cells treated with increasing concentrations ...
<p><b>A)</b> G2/M arrest in HCT116 colon cancer cells. HCT116 cells were treated with the indicated ...
International audienceThe inhibitor of caspase-3-activated DNase (ICAD) is a caspase-3 substrate tha...
<p><b><i>A</i></b>, Cells were treated with RTA 408 for 72 hours and viability was assessed using th...
TW-37 is a small-molecule inhibitor of Bcl-2 family proteins, which can induce anti-cancer activitie...
<p>(A) Two cancer cell lines were cultured with the indicated doses of TRAIL and CQ for 48 h. After ...
<p>HCT-8 cells at 50% confluence were treated with or without FL118 (10 nM) for 24 hours and were la...
<p>(A) EVO reduction of cell viability of COLO205, HT-29, NIH3T3, and WI-38 cells by an MTT assay. T...
<p>(A) Flow cytometric analysis of cell surface gp96 levels in breast cancer cells. (B) Cells were t...
Colorectal cancer (CRC) is one of the most common cancers in the Western world. 5-Fluorouracil (5FU)...
<p>(A) Apoptotic cells in IEC-18 cells pretreated with TLE (100 µg/ml; 45 min) and stimulated with T...
TW-37 is a novel, potent and non-peptide Bcl-2 small-molecule inhibitor. Its activity in colorectal ...
<p>A, HT-29 and T84 cells were treated for 24 h. Enzymatic activation of caspases 2, 3/7, 6, 8 and 9...
<p>Established CRC cell lines (HT-29, HCT116 and DLD-1), primary human CRC cells (two lines, “Pri1/2...
<p>a) Representative dot plot shows that, compared to vehicle-treated control cells, a significantly...
<p><b>A</b>. Caspase 3/7 activity of HT1080 and HCT116 cells treated with increasing concentrations ...
<p><b>A)</b> G2/M arrest in HCT116 colon cancer cells. HCT116 cells were treated with the indicated ...
International audienceThe inhibitor of caspase-3-activated DNase (ICAD) is a caspase-3 substrate tha...
<p><b><i>A</i></b>, Cells were treated with RTA 408 for 72 hours and viability was assessed using th...
TW-37 is a small-molecule inhibitor of Bcl-2 family proteins, which can induce anti-cancer activitie...
<p>(A) Two cancer cell lines were cultured with the indicated doses of TRAIL and CQ for 48 h. After ...
<p>HCT-8 cells at 50% confluence were treated with or without FL118 (10 nM) for 24 hours and were la...
<p>(A) EVO reduction of cell viability of COLO205, HT-29, NIH3T3, and WI-38 cells by an MTT assay. T...
<p>(A) Flow cytometric analysis of cell surface gp96 levels in breast cancer cells. (B) Cells were t...
Colorectal cancer (CRC) is one of the most common cancers in the Western world. 5-Fluorouracil (5FU)...
<p>(A) Apoptotic cells in IEC-18 cells pretreated with TLE (100 µg/ml; 45 min) and stimulated with T...